Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Shifting narrative
View:
Post by N0taP00p on Feb 24, 2023 11:47am

Shifting narrative

The PPPs (perennially positive people) have started shifting the narrative ever so subtly to "we always expected that 2025 was the year" which is a bad sign. Let's hope the next report has enough high octane beans to float this baby up.  And let's hope there's no more dilution.  To BTD and beyond. Stay rationally foolish.
Comment by Rumpl3StiltSkin on Feb 24, 2023 12:51pm
Notachance, Some of us were thrown off a bit, me included, yesterday by Dr. Uddins article. He clearly wasn't counting on TLT receiving AA here in '23 or early '24.
Comment by Lesalpes29 on Feb 24, 2023 1:28pm
I'm in the impression it's a liilte bit urgent to give an other alternative to the patients. I really think AA is going to be in 2023. GL
Comment by Donein25 on Feb 24, 2023 2:50pm
Might I add that analysts have no idea what conversations are going on anyway; be it with FDA or with even pharma. No large pharma is gonna sit on the sidelines and just wait. In this past year, which was a tough one for the sector, CEO after CEO at large pahrmas have talked about looking for deals that make sesne and bring new streams of revenue in the near future... There is fierce competition ...more  
Comment by N0taP00p on Feb 24, 2023 3:14pm
Donein25 - What are your thoughts on the generally abysmal and erratic trading volumes of this stock? Tells me it's not on the radar yet. News generally leaks if many pharmas are monitoring.  BTD is the only way this gets picked up by the folks that really matter, the ones with either influence or money. So it might be a while before they get offers for JVs or buyouts.  Seems like ...more  
Comment by Donein25 on Feb 24, 2023 3:36pm
I sure hope it's sooner. Been here 9 years. But for all us longs, the stock price has gone nowhere for this whole time. Multiple reasons; the large float, the penny flippers, lack of visibility, dilution, absence of a true CEO for 5 years etc. etc. All that said, no market factors will stop eventual commercialization of a viable cancer treatment. The data will lead us to where we belong!
Comment by Paradise818 on Feb 24, 2023 4:59pm
Also been in this stock for about the same time, have >300,000 shares. Read all kinds of predictions but this is still a .28 cent stock until we get concrete news regarding BTD and AA.  I am in it for the long haul but 9 years is a long time.
Comment by DJDawg on Feb 24, 2023 3:41pm
I am very skeptical about the trading volumes and what they mean. We know: - about 216 m shares outstanding (not counting warrants) - we know that insiders have easily 20 m shares that they have not sold as it would be reported - we know that there are a lot of dedicated longholders. Many of whom indicate that they own a lot of shares. I don't know what that means but if the average ...more  
Comment by N0taP00p on Feb 24, 2023 5:01pm
DjDawg and Donein25: Thanks.  By the end of next week, we'll hopefully know where things are at, especially wrt funds and FDA.  Good weekend to all. 
Comment by Legit62 on Feb 25, 2023 8:58am
I totally agree, most longs have a bunch of shares, i bought more when it got into low .20s and am averaged in in the teens with a high volume of shares, my feeling is longs are not buying or selling but we have a handfull of day traders try to swing market lower to grab shares and make a quick  (SMALL) profit, until we get news of a JV or untill we receive AA, we sit in the doghouse. So my ...more  
Comment by Paradise818 on Feb 25, 2023 2:20pm
Go out, live your life, have fun.  Our time will come.  Hopefully sooner than later.
Comment by menoalittle on Feb 24, 2023 5:32pm
>> BTD is the only way this gets picked up by the folks that really matter,  >> the ones with either influence or money. The simple fact here is that big pharm (aka, BIG MONEY) would rather pay a much, much higher price for something proven (i.e., has AA, or at the very least, BTD) than any of them ever would (or will) for something without it. So... personally, I'm happy to ...more  
Comment by Longholder99 on Feb 24, 2023 8:15pm
Agree menoalittle. When it will make money it will be worth money.  
Comment by consultant99 on Feb 25, 2023 6:52pm
The simple fact here is that big pharm (aka, BIG MONEY) would rather pay a much, much higher price for something proven (i.e., has AA, or at the very least, BTD) than any of them ever would (or will) for something without it. I totally agree with this assertion having worked in business development for a large energy company. This is a great deal of risk associated in buying unproven technology ...more  
Comment by BlueFranky on Feb 25, 2023 7:06pm
Solid post, Consultant! ;-)
Comment by jmm1228 on Feb 25, 2023 8:05pm
Astute comment! Very helpful at this critical time.
Comment by N0taP00p on Feb 24, 2023 1:38pm
Rumpl3, FWIW we all needed that sobering down of expectations. I started worrying a bit more when they extended expiring warrants.  But hey, if what we're hoping for becomes reality in a few months, we won't even be posting here. Keeping my fingers crossed that we finally see this stock climb out of the multi year ditch it's been in 
Comment by Rumpl3StiltSkin on Feb 24, 2023 2:55pm
Yep Poop, I'm hoping so.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250